• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Venous thromboembolism rates in hospitalized children continue to rise

byMolly MunsellandAlex Gipsman, MD
February 14, 2022
in Chronic Disease, Emergency, Hematology, Oncology, Pediatrics
Reading Time: 3 mins read
siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Share on FacebookShare on Twitter

1. In a large retrospective study, rates of venous thromboembolism (VTE) in pediatric patients increased from 46 to 106 per 10,000 hospital admissions between 2008 and 2019.

2. 78% of patients with a VTE admission had chronic complex medical conditions compared to 27% of patients without a VTE admission.

Evidence Rating Level: 2 (Good)

Study Rundown: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant cause of morbidity in children and adults alike. Hospitalized patients are at particularly high risk due to immobilization in addition to underlying disease states. This large, multicenter study aimed to quantify changes in VTE rates in hospitalized children between 2008 and 2019, replicating the methods of a previous study. Between 2001 and 2007, VTE rates had increased from 38 to 53 in 10,000. In the current study, almost 40,000 pediatric patients were diagnosed with VTE during more than 52,000 admissions. The rate of VTE increased from 46 cases per 10,000 admissions in 2008 to 106 per 10,000 in 2019, representing a 130% increase. The largest increases were in the adolescent age group, with 31% of VTE patients between the ages of 13 and 17, and in infants younger than 1 year. 78% of VTE patients had an underlying chronic complex condition, with a median of 3 conditions, compared to 27% of patients without VTE. 35% of VTE patients were dependent on technology such as gastrostomy or tracheostomy tubes or pacemakers. Due to limitations of the data, it is unclear what proportion of patients were initially admitted for VTE rather than having a VTE in the hospital. It is also unclear how much of the greatly increased VTE rate is due to higher rates of detection compared to a true increase in VTE. Though these questions and the risk factors for hospital VTE require further study, this study shows the worsening of a clear and urgent problem in pediatric hospital care. As more highly complex patients are cared for in pediatric hospitals, including patients with central venous catheters, protocols for VTE prophylaxis must be re-examined and updated.

Click to read the study in Pediatrics

Relevant Reading: Prevention of hospital-acquired venous thromboembolism in children: A review of published guidelines

RELATED REPORTS

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

Artificial intelligence-guided ultrasound lacks sufficient accuracy for deep vein thrombosis detection

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

In-Depth [retrospective cohort]: Retrospective data were drawn from the Pediatric Health Information System database, which represents 49 hospitals. ICD codes were used to identify all admissions with a DVT or PE recorded. Children from birth to 18 years old were included. The p-value was <0.0001 for the 130% increase in VTE events between 2008 and 2019 and for each age group. 35.4% of VTEs were upper extremity DVT, 28.4% lower extremity, and 9.1% PE. Compared to admissions without VTE, VTE admissions were longer, with a median length of stay of 13 days compared to 3 days and patients older, with a median age of 5.2 years compared to 3.8 years. VTE admissions were less likely to include an emergency department visit and more likely to include surgery, PICU admission, or NICU admission than admissions without a VTE. Enoxaparin was the most commonly prescribed therapy for VTE. Direct oral anticoagulants were used during 3% of admissions in 2019.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: central venous cathetersdeep vein thrombosis (DVT)pulmonary embolismvenous thromboembolism (VTE)
Previous Post

The religious and spiritual beliefs of cancer patients may influence decision making

Next Post

Oral HIV preexposure prophylaxis limits willingness to pay for long-acting injectable prophylaxis

RelatedReports

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Pharma

Apixaban reduces bleeding risk versus rivaroxaban in acute venous thromboembolism

March 23, 2026
Patient Basics: Ultrasound
2 Minute Medicine

Artificial intelligence-guided ultrasound lacks sufficient accuracy for deep vein thrombosis detection

August 22, 2025
#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation
StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025
#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients
StudyGraphics

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

March 10, 2025
Next Post
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Oral HIV preexposure prophylaxis limits willingness to pay for long-acting injectable prophylaxis

Mild-to-moderate hypertriglyceridemia associated with higher risk of acute pancreatitis

Immediate drainage of infected necrotizing pancreatitis shows no benefit over postponed drainage

Patient Basics: Cervical Cancer

Cemiplimab treatment of recurrent cervical cancer is associated with longer overall survival

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in